News about Medicine

NNF Challenge Programme grant of DKK 60 awarded to Professor Nikos Hatzakis

The Novo Nordisk Foundation has awarded a Challenge Programme grant of DKK 60 million to Professor Nikos Hatzakis for realising the drugs of the future.

Refurbishment of breeding unit 10-4 in the Panum Building

AEM is in collaboration with Campus Service (CAS) planning a much needed renovation of the breeding unit at 10-4 in the Panum Building which will commence April 2024. Prior to that the unit needs to be vacated. AEM will…

Thousands suffer from tabooed disease. New method makes it easier to identify the right treatment

More than 10 urgent visits to the bathroom a day due to diarrhoea can make it virtually impossible to lead a normal life. But new research can help doctors diagnose bile acid diarrhoea and find the right treatment.

Michael Ploug receives research grant to study the breakdown of fat in the smallest blood vessels

BRIC/Finsen Group Leader, Michael Ploug, and his Network Receives a Research Grant to Study the breakdown of fat in the smallest blood vessels.

Need help to quit smoking? Known drug might help reduce nicotine cravings

A drug that was originally developed to treat diabetes and severe overweight might also help people with nicotine dependence, concludes new research from the University of Copenhagen.

PartoMa at IMNHC: The injustice of unfit clinical guidelines in women’s and children’s health

On Wednesday, May 10th, the PartoMa team will host a thematic session at IMNHC titled "The Missing Link between Clinical Guidelines and Clinical Realities: Aligning Together." The session will be moderated by Thomas van…

CBMR secures five-year funding extension from Novo Nordisk Foundation

Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen is awarded up to DKK 1 billion (€134.2 million) from the Novo Nordisk Foundation.

The University of Copenhagen invests in the development of medicines from health-promoting gut bacteria

The University of Copenhagen is the first Danish university to invest in a company based on its own research in a unique collaboration with a venture fund. In April 2023, the spinout GutCRINE ApS received initial fundin…

BRIC/Finsen spinout Adcendo Aps moves forward towards clinical trials

Closing a Series A extension financing of 31 million euro will allow BRIC/Finsen spinout Adcendo ApS to conduct broad phase 1 testing of their uPARAP ADC, starting by the end of 2024.

Hormone predicts ability to maintain weight loss

The appetite hormone neurotensin released by the intestine upon eating may predict our ability to maintain weight loss, new study from the University of Copenhagen concludes.

New malaria study is good news for pregnant women

Each year, 13 million pregnant women get malaria, and as drug resistance increases, the disease is hard to control. A new study provides the WHO with new knowledge on prevention and treatment.

Risk of heart problems makes Danes get flu vaccination

More Danes got vaccinated for the seasonal flu if they received a nudging letter from the health authorities, which linked the flu and the risk of subsequent heart problems, study concludes.

Bartender model predicts how drugs affect each person

A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.

Bartender model predicts how drugs affect each person

A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.

Resistant bacteria are a global problem. Now researchers may have found the solution

A new substance has proven useful for treating staphylococcus infections in people with skin lymphoma. This is good news for the patients, but also for the global threat of antibiotics resistance.

The deadline for the submission to European Journal of Pharmaceutical Sciences VSI: Nordic POP has been extended until May 31

Good news for those that are planning to submit to European Journal of Pharmaceutical Sciences VSI: Nordic POP and are running a bit late!. The submission deadline has been moved to May 31, 2023. Hope for a rush of…

Nature’s future pharmacy in peril

For thousands of years, people have relied on the healing properties of plants – in some places they are still the only freely available remedies to this day. Half of the drugs approved worldwide in the last four decade…

Nature’s future pharmacy in peril

For thousands of years, people have relied on the healing properties of plants – in some places they are still the only freely available remedies to this day. Half of the drugs approved worldwide in the last four decade…

The deadline for the submission to European Journal of Pharmaceutical Sciences VSI: Nordic POP is near!

The submission deadline to European Journal of Pharmaceutical Sciences VSI: Nordic POP is closing March 31, 2023.

Previously unknown cell mechanism could help counter cancer and aging

In a new study, researchers from the University of Copenhagen discovered an unknown mechanism of how cells ‘remember’ their identity when they divide – the cells’ so-called epigenetic memory.

Change in transfer and breeding instruction forms and reviewing the department’s SOPs

Please read the information here.

Power shutdown at the Biocenter

The power shutdown applies to the entire basement in building 2. It will affect ventilation and other installations in animal facility, including lights (electronic board 2.01.AB). If the shutdown gives rise to…

A more efficient technology for oromucosal drug delivery

The project SAFE Patch recently received 1.5 mill DKK from the Innovation Fund Denmark’s InnoExplorer program to explore and develop the new “SAFE Patch” technology and bring it closer to commercialization.

Construction work near the Biocenter - Test piloting performed

The piloting will begin on Monday Janurary 30th, and it is expected to last approx. 10 working days. AEM is still in dialogue with the contractor, and should you experience any irregularities, you are very welcome to…